Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Eiken Chemical Co., Ltd. ( (JP:4549) ) just unveiled an announcement.
Eiken Chemical Co., Ltd. has announced its opposition to a shareholder proposal submitted by AVI Japan Opportunity Trust PLC, which will be presented at the upcoming Annual General Shareholders Meeting. The proposal includes amendments to the articles of incorporation and a buyback of shares. The company’s board believes that decisions regarding dividends should align with management strategies and be determined by the board to enhance corporate and shareholder value in the long term. Eiken Chemical has committed to a shareholder return policy with a target total return ratio of at least 50% from March 2026, emphasizing their focus on capital efficiency and shareholder profit.
More about Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. operates in the chemical industry, focusing on the development and production of diagnostic reagents and equipment. The company is known for its contributions to medical diagnostics and aims to enhance healthcare through innovative solutions.
Average Trading Volume: 103,305
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen71.28B
For detailed information about 4549 stock, go to TipRanks’ Stock Analysis page.